Addressing the Real-World Challenges of Immunoresistance to Botulinum Neurotoxin A in Aesthetic Practice: Insights and Recommendations from a Panel Discussion in Hong Kong

With increasing off-label aesthetic indications using higher botulinum neurotoxin A (BoNT-A) doses and individuals starting treatment at a younger age, particularly in Asia, there is a greater risk of developing immunoresistance to BoNT-A. This warrants more in-depth discussions by aesthetic practit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Wilson W. S., Chan, Lisa, Corduff, Niamh, Lau, Wang-Tak, Martin, Michael U., Tay, Clifton Ming, Wang, Sandy, Wu, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467074/
https://www.ncbi.nlm.nih.gov/pubmed/37505725
http://dx.doi.org/10.3390/toxins15070456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467074/
https://www.ncbi.nlm.nih.gov/pubmed/37505725
http://dx.doi.org/10.3390/toxins15070456

Ejemplares similares